Pa Shun International Holdings (HKSE:00574) Other Financing: HK$-0.81 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Pa Shun International Holdings Other Financing?

Pa Shun International Holdings HKSE:00574 Other Financing is HK$-0.81 Mil as of Dec. 2025. The stock has 9 warning signs investors should review.

Pa Shun International Holdings's Other Financing for the six months ended in Dec. 2025 was HK$-0.81 Mil.

Pa Shun International Holdings's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.81 Mil.

Pa Shun International Holdings Other Financing Historical Data

* Premium members only.

The historical data trend for Pa Shun International Holdings's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pa Shun International Holdings Other Financing Chart

Pa Shun International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.57 -0.72 8.00 -1.19 -0.81

Pa Shun International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.76 0.00 -1.19 0.00 -0.81

Pa Shun International Holdings Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.81 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of HK$-0.81 Mil mean?
Pa Shun International Holdings (HKSE:00574) has a Other Financing of HK$-0.81 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Pa Shun International Holdings and its competitors.
Is Pa Shun International Holdings' Other Financing too high?
Pa Shun International Holdings' current Other Financing is HK$-0.81 Mil.
How does Pa Shun International Holdings' Other Financing compare to competitors?
Pa Shun International Holdings' Other Financing of HK$-0.81 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Pa Shun International Holdings and its competitors. Pa Shun International Holdings's current Other Financing is HK$-0.81 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pa Shun International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Pa Shun International Holdings (HKSE:00574) is currently considered Possible Value Trap. The stock's GF Value™ is HK$0.03, compared to a current price of HK$0.02 — trading 40% below its estimated fair value. The current Other Financing is HK$-0.81 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Pa Shun International Holdings (HKSE:00574), the current Other Financing is HK$-0.81 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pa Shun International Holdings Business Description

Address 6- 8 Harbour Road, Suites 2601-2603, 26th Floor, Shui On Centre, Wanchai, Hong Kong, HKG
Pa Shun International Holdings Ltd is an investment holding company engaged in the manufacturing and distribution of pharmaceutical products. The business activity of the group is operated through Pharmaceutical distribution and Pharmaceutical manufacturing segment. Geographically all the activities are carried out in the PRC. The company derives the majority of revenue from the Pharmaceutical distribution segment which include sales of pharmaceutical products to wholesalers, franchise retail pharmacy chain stores and hospitals and other medical institutions in rural areas.